Image Credit: Canva
A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.
Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.
The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.
Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.
Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.
Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.
Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.
These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.
Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:
Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.
Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.
Blood Tests: High levels of HGA in the blood can be used as further evidence.
Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.
At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:
Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.
Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.
Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.
Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.
Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.
Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.
Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.
As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.
Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.
Credit: iStock
Lung development of the fetus depends on the physical and genetic health of the parents.
At birth, breathing begins with air from the environment, containing oxygen and other gases, and is influenced by known and unknown forces of nature. The air then passes through well-developed nostrils, which regulate the air temperature and prevent foreign bodies from entering the body and help protect against diseases.
Breath travels through the nasal passages, sinuses, pharynx (throat), larynx (voice box), trachea (breathing tubes), bronchi, small airways, air sacs, interstitial membrane, into thin-walled blood vessels that transport oxygen and collect gases and other substances to be expelled from the body.
The diaphragm, the muscle that separates the lungs from the abdomen, is the most powerful breathing apparatus.
The lungs in the early stages of life undergo dramatic changes from newborn→ infancy→ childhood→ puberty→ teenage→ adults→ middle age→ seniors. Factors influencing lung health risks keep changing with age, depending on genetics, environment & external factors.
The lungs and airways perform non-respiratory functions of protecting the body against harmful insults, both from within and external threats, and it also protects against insults received from other organs of the body. The lungs have a powerful defense mechanism protecting the body and also have hormonal, physical, and immunological defense mechanisms.
Alcohol awareness and the health risks associated with drinking, marking World No Alcohol Day. (Image Credits: iStock)
Every year on October 2, World No Alcohol Day urges people to pause and think about alcohol's place in everyday life. Here's where the day came from, and what current research actually shows about drinking.
It began in 2008, when India's then Union Health Minister, Dr. Anbumani Ramadoss, proposed a global alcohol-free day at the World Health Assembly in Geneva, according to National Day Calendar. The proposal drew support from 11 Southeast Asian countries.
The World Health Organization never formally adopted October 2 as an official global observance, according to a summary on Checkiday. There are, in fact, three dates tied to alcohol awareness worldwide: October 2 and October 3, observed by many groups as World Alcohol-Free Day or World Temperance Day, and November 15.
In India, October 2 is also a nationwide dry day, with no alcohol sales permitted, and is marked separately as National Anti-Drug Addiction Day.
The science has shifted since 2008. In January 2023, the World Health Organization stated plainly that no level of alcohol consumption is safe for health, publishing the position in The Lancet Public Health. The WHO said current evidence cannot identify any threshold below which alcohol's cancer-causing effects switch off.
Alcohol is classified as a Group 1 carcinogen, the same risk category as tobacco and asbestos, and is linked to at least seven types of cancer, including the most common cancers in men and women, bowel and breast cancer, according to the WHO.
Globally, alcohol was responsible for an estimated 741,300 new cancer cases and contributed to nearly 400,000 cancer deaths in a single year, as per Lancet-based estimates cited by the Union for International Cancer Control.
Previous research has showed some benefits of wine, but the majority scientific consensus now is that there is no safe levels of alcohol. The World Health Organization says health risks begin with the first drop of alcohol, meaning no level of consumption is completely safe or risk-free.
Cancer isn't the only risk. Alcohol use is tied to roughly 2.5 million deaths worldwide each year, including 320,000 among people aged 15 to 29, according to the WHO. Beyond individual health, alcohol-related harm also means more road accidents, violence, and strain on healthcare systems.
A May 2026 study linked alcohol to 62 disorders, ranging from heart and digestive diseases to mental and neurological conditions and cancers.
The study, published in the journal Addiction, showed that the fully alcohol-attributable conditions are mainly grouped under non-communicable diseases and injuries.
These include:
The data also included psychotic disorders, gastritis, ulcers, pancreatitis, fatty liver disease, pregnancy- and perinatal-related conditions such as fetal alcohol syndrome and fetal alcohol spectrum disorders, as well as external causes and injuries, including alcohol poisoning.
Excessive alcohol consumption is one of the leading preventable causes of illness and death in the US, according to the Centers for Disease Control and Prevention.
Research shows that alcohol accounts for approximately half of all liver-related deaths, while alcohol-associated cirrhosis has become the leading cause of liver transplants.
Credit: Instagram
Actress Amanda Peet has opened up about her breast cancer diagnosis, revealing a “weird” change in the skin that did not feel like the typical lump many people associate with breast cancer.
A breast lump is a well-known warning sign of breast cancer, but the disease can also cause changes in the breast’s skin, shape or texture. This makes it important to pay attention to changes that may not feel like a distinct lump.
Peet, 54, recalled noticing something unusual while getting dressed.
“I was in my closet, I was probably putting something on and I felt a weird — it just didn’t feel like normal skin, but it wasn’t the frozen pea that everybody talks about,” she told Today.com.
Peet described the sensation as a change in how the skin felt rather than a clearly defined lump.
Other breast cancer warning signs can include changes in breast size or shape, skin dimpling, swelling, redness, nipple changes or unusual discharge. Skin that becomes pitted and resembles an orange peel, known as peau d’orange, can also be a warning sign.
Importantly, breast cancer can sometimes be present without an obvious lump.
Peet had been undergoing regular breast screening and follow-up because of her breast health history. She has said that an MRI did not show the cancer, but a subsequent ultrasound detected an abnormality. A biopsy later confirmed a tumor.
She was diagnosed with hormone-receptor-positive, HER2-negative invasive lobular carcinoma and underwent a lumpectomy followed by radiation.
Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer and accounts for about 10% of invasive breast cancers.
Unlike many breast cancers that form a distinct lump, ILC can grow in a more diffuse pattern. It may cause thickening, fullness or a subtle change in the breast rather than a clearly defined mass.
Because of the way ILC grows, it can sometimes be harder to detect on mammography. Additional imaging, including ultrasound or MRI, may be used depending on an individual's symptoms, breast density and clinical assessment.
Most invasive lobular cancers are hormone-receptor positive. Peet wrote that she had been seeing a breast surgeon every six months for checkups. Her cancer was diagnosed at Stage 1.
“I think about how lucky I was in so many ways,” she said.
Breast cancer screening is designed to detect cancer before signs or symptoms become apparent. The goal is early detection, when treatment may be more effective.
The appropriate screening schedule depends on age, breast cancer risk, family history and other factors. In the US, the US Preventive Services Task Force recommends that women at average risk aged 40 to 74 have a mammogram every two years.
People with a higher risk of breast cancer may need a different screening approach or additional imaging. Discussing individual risk and screening options with a healthcare professional can help determine what is appropriate.
October marks Breast Cancer Awareness Month, with this year’s theme, “Every story is unique, every journey matters,” highlighting that every breast cancer experience is different.
According to the World Health Organization (WHO), breast cancer is the most common cancer among women. About 80% of breast cancers occur in women with no specific risk factors other than sex and age.
In 2024:
© $2026 Times Horizon Private Limited